Literature DB >> 2833974

Safety of surveillance in the management of stage I anaplastic germ cell tumours of the testis.

S M Crawford1, G J Rustin, R H Begent, E S Newlands, K D Bagshawe.   

Abstract

A study was made of 46 patients with anaplastic germ cell tumours of the testis with no evidence of disease elsewhere as judged by computed tomography (CT) of thorax and abdomen, ultrasound and tumour marker measurements. A repeat CT 3 months after the first and clinical examination with chest X-ray and tumour marker measurements ensured that the 30.7% of patients who relapsed were detected promptly enough for them all to enter complete remission. Lymphography as part of the staging did not reduce the relapse rate. There was no difference between this group and a comparable group who underwent radiotherapy to para-aortic lymph nodes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2833974     DOI: 10.1111/j.1464-410x.1988.tb06389.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  4 in total

1.  Testicular self examination: evaluation of an educational leaflet.

Authors:  S M Crawford; G M Littlejohn; P G Kamill
Journal:  Br J Gen Pract       Date:  1991-04       Impact factor: 5.386

2.  Imaging of testicular germ cell tumours.

Authors:  P U Dalal; S A Sohaib; R Huddart
Journal:  Cancer Imaging       Date:  2006-09-07       Impact factor: 3.909

3.  Frequency of serum tumour marker monitoring in patients with non-seminomatous germ cell tumours.

Authors:  M J Seckl; G J Rustin; K D Bagshawe
Journal:  Br J Cancer       Date:  1990-06       Impact factor: 7.640

Review 4.  Surveillance in testicular cancer: who, when, what and how?

Authors:  S A Sohaib; J Husband
Journal:  Cancer Imaging       Date:  2007-10-22       Impact factor: 3.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.